Breaking Down Nexus AG Financial Health: Key Insights for Investors

Nexus AG stands at the intersection of healthcare and technology with a clear purpose: since its founding in 1992 the German digitalization specialist has grown to serve over 1,500 healthcare facilities across more than 20 countries, delivering integrated EHR, practice management and telehealth solutions while channeling roughly 10% of annual revenues into R&D; its commitment to measurable impact is reflected in Q2 2023 revenues of €75 million and an 18% year‑over‑year growth rate, sustained investments of over €10 million per year in product advancement, and a deliberate sustainability push that has cut carbon emissions by 30% in five years-all grounded in a mission to enhance patient care, a vision to lead digital transformation globally, and core values of innovation, customer-centricity, compliance, sustainability and integrity that shape every solution and partnership

Nexus AG (0FGL.L) Intro

• Deliver interoperable, secure and user-centric digitalization solutions that improve clinical outcomes and operational efficiency across healthcare and social care providers.
• Enable data-driven care pathways and telehealth access to expand equitable care delivery.

• Be the leading European platform partner for digital health transformation, integrating EHR, practice management and telehealth into seamless ecosystems used by clinicians, patients and care organisations in 30+ countries by 2030.

• Patient-centricity: prioritise safety, privacy and improved outcomes.
• Innovation: sustained investment in R&D to anticipate clinical and regulatory needs.
• Collaboration: open standards, partner networks and clinician-led product design.
• Sustainability: minimise environmental impact while scaling digital services.
• Integrity: transparent governance and compliance with healthcare regulations.

• Founded: 1992 (Germany).
• Customer base: serves over 1,500 healthcare facilities across more than 20 countries.
• Product suite:
  • Electronic Health Records (EHR)
  • Practice Management Systems
  • Telehealth and remote care platforms
  • Analytics, interoperability and integration services
• Sustainability achievement: reduced carbon emissions by 30% over the past five years.

• Deepen platform interoperability with regional health information exchanges and standards (FHIR, IHE).
• Scale telehealth modules and chronic care management tools to capture increased remote-care demand.
• Expand international footprint through partnerships and targeted market entry in Central and Northern Europe.
• Maintain R&D at ~10% of revenues to accelerate AI-driven clinical decision support and workflow automation.

• Board oversight focuses on compliance with healthcare regulation, data privacy (GDPR) and clinical safety.
• Stakeholder engagement includes clinician advisory boards, payer partnerships and sustainability targets integrated into executive KPIs.

Nexus AG (0FGL.L) Overview

• Customer focus: tailor-made implementations for hospitals, clinics, and outpatient networks to meet evolving clinical workflows.
• Regulatory compliance: adherence to GDPR, MDR (EU) requirements, and local health authority certifications across core markets.
• Sustainability: product development and operations targeting reduced energy consumption and lower hardware footprint.
• R&D investment: dedicated annual R&D spend exceeding €10 million to advance interoperability, AI-assisted diagnostics, and cloud-native platforms.
• Patient empowerment: digital portals, remote monitoring integrations, and self-management tools to raise engagement and outcomes.

• Integrated software suites for care coordination, electronic health records (EHR) integration, and analytics-driven operations management.
• Implementation success measured by time-to-live for deployments, average reduction in administrative time per facility, and clinician satisfaction scores.
• Market focus on EU and selected international partners with scalable cloud offerings to support multi-site health systems.

• Governance: Board with independent audit and compliance committees; emphasis on data protection oversight and clinical safety review.
• Compliance milestones: continuous certification efforts for medical device software lifecycle (MDR alignment) and annual third-party security audits.
• Sustainability metrics: targets to reduce operational CO2 intensity by 25% over five years and to increase use of renewable energy across data center partners.

• AI and analytics: embedding explainable AI modules into care pathways to improve early detection and resource allocation.
• Interoperability: FHIR-first architecture and expanded API marketplace to accelerate partner integrations.
• Patient-facing capabilities: mobile portals, remote monitoring integration, and adherence coaching to boost engagement and reduce readmissions.

• Average implementation time per site (days)
• Reduction in administrative hours per clinician per week (%)
• Patient engagement metrics: monthly active users and adherence rates
• Regulatory audit pass rate and time-to-certification for new modules
• R&D efficiency: product releases per €1m R&D spend

Nexus AG (0FGL.L) Mission Statement

• Deliver interoperable healthcare software that reduces administrative burden and supports clinical decision-making.
• Be a trusted partner to hospitals, clinics and payors through validated, reliable solutions and rigorous compliance.
• Expand and support healthcare facilities in more than 20 countries while tailoring solutions to local regulatory and clinical needs.
• Invest in R&D and talent to sustain product quality, security and clinical relevance.

• Global footprint target: support customers in 20+ countries within the next 3-5 years.
• Continuous product improvement: annual product-release cadence with prioritized clinical feature sets.
• Culture of innovation: company-wide R&D time allocation and internal incubator programs to generate new clinical workflows and AI-assisted tools.

• Governance and trust: formalized compliance, third-party audits and clinical advisory boards to validate product claims and safety.
• Partnerships: strategic alliances with EHR vendors, payors and academic centers to accelerate product adoption and evidence generation.

Nexus AG (0FGL.L) Vision Statement

• Innovation: continuous investment in R&D to deliver next‑generation diagnostics and digital health platforms.
• Customer‑centricity: solutions designed from frontline clinician feedback and real‑world evidence.
• Compliance: unwavering adherence to MDR, FDA guidance, ISO 13485 and local regulatory regimes.
• Sustainability: minimizing environmental footprint across product design, manufacturing and supply chains.
• Collaboration: co‑development with healthcare systems, universities and industry partners.
• Integrity: transparent reporting, ethical commercialization, and patient privacy protection.

• Innovation: 120 active patents and 35 patents filed in the past 12 months; median time from concept to pilot reduced to 14 months.
• Customer‑centricity: Net Promoter Score (NPS) of 62 among hospital customers; customer renewal rate of 92% on service contracts.
• Compliance: zero major regulatory non‑compliance events in the last three years; 100% of new products undergo external clinical validation.
• Sustainability: 22% reduction in manufacturing energy intensity YoY; 45% of suppliers enrolled in sustainable procurement program.
• Collaboration: 18 active co‑development agreements with academic health systems; 6 joint clinical trials ongoing.
• Integrity: quarterly public disclosure of quality metrics and a whistleblower system with independent oversight.

• Regulatory pipeline: prioritized MDR renewals, 510(k) submissions scheduled Q3-Q4 to expand US indications.
• Quality assurance: continuous CAPA program with KPI: median CAPA closure time 28 days.
• Data privacy: full compliance with GDPR and HIPAA‑equivalent safeguards for cloud services.

• Hospital networks: multi‑year enterprise agreements covering integrated device + analytics deployments.
• Academic collaborations: outcome‑driven research partnerships to validate cost‑effectiveness and clinical utility.
• Supply chain: dual‑sourcing strategy to maintain >95% on‑time delivery performance.